EXI1:XETRA:XETRA-iShares SLI UCITS ETF (DE) (EUR)

ETF | Others |

Last Closing

USD 141.98

Change

-0.16 (-0.11)%

Market Cap

USD 0.37B

Volume

3.34K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

NA

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-01-14 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

-0.28 (-0.55%)

USD 446.30B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

-0.08 (-0.50%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

-0.13 (-0.46%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

-0.13 (-0.47%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

-0.17 (-0.67%)

USD 157.79B
JARI:XETRA Amundi Index Solutions - Amund..

-0.27 (-0.61%)

USD 104.21B
8R80:XETRA Amundi Index Solutions - Amund..

+1.38 (+1.00%)

USD 102.09B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

-0.26 (-0.51%)

USD 85.64B
EUNL:XETRA iShares Core MSCI World UCITS ..

-0.19 (-0.18%)

USD 84.07B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-1.32 (-0.22%)

USD 80.38B

ETFs Containing EXI1:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.28% 77% C+ 72% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.28% 77% C+ 72% C
Trailing 12 Months  
Capital Gain 9.03% 47% F 50% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 9.03% 45% F 48% F
Trailing 5 Years  
Capital Gain 36.34% 65% D 67% D+
Dividend Return 4.27% 19% F 16% F
Total Return 40.60% 66% D+ 66% D+
Average Annual (5 Year Horizon)  
Capital Gain 9.83% 64% D 63% D
Dividend Return 10.14% 64% D 63% D
Total Return 0.31% 34% F 22% F
Risk Return Profile  
Volatility (Standard Deviation) 11.82% 54% F 63% D
Risk Adjusted Return 85.81% 76% C+ 79% B-
Market Capitalization 0.37B 59% D- 52% F

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
Below median total returns

The company has under performed its peers on annual average total returns in the past 5 years.